Design, synthesis and molecular modeling of isothiochromanone derivatives as acetylcholinesterase inhibitors

被引:6
作者
Shuai, Wen [1 ,2 ]
Li, Wenlong [1 ,2 ]
Yin, Ying [1 ,2 ]
Yang, Limei [1 ,2 ]
Xu, Feijie [1 ,2 ]
Xu, Shengtao [1 ,2 ]
Yao, Hequan [1 ,2 ]
Zhu, Zheying [3 ]
Xu, Jinyi [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, 24 Tong Jia Xiang, Nanjing 210009, Jiangsu, Peoples R China
[3] Univ Nottingham, Sch Pharm, Div Mol Therapeut & Formulat, Univ Pk Campus, Nottingham NG7 2RD, England
基金
中国国家自然科学基金;
关键词
acetylcholinesterase inhibitor; Alzheimer's disease; dual binding site; isoselenochromanone; isothiochromanone; BENZYL PYRIDINIUM MOIETY; ALZHEIMERS-DISEASE; BIOLOGICAL EVALUATION; HYBRIDS; DONEPEZIL; POTENT; DOCKING;
D O I
10.4155/fmc-2019-0125
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Aim: A series of novel isothio- and isoselenochromanone derivatives bearing N-benzyl pyridinium moiety were designed, synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. Results: Most of the target compounds exhibited potent anti-AChE activities with IC50 values in nanomolar ranges. Among them, compound 15a exhibited the most potent anti-AChE activity (IC50 = 2.7 nM), moderate antioxidant activity and low neurotoxicity. Moreover, the kinetic and docking studies revealed that compound 15a was a mixed-type inhibitor, which bounds to peripheral anionic site and catalytic active site of AChE. Conclusion: Those results suggested that compound 15a might be a potential candidate for AD treatment. [GRAPHICS] .
引用
收藏
页码:2687 / 2699
页数:13
相关论文
共 20 条
[11]   Benzofuran-based hybrid compound's for the inhibition of cholinesterase activity, β amyloid aggregation, and Aβ neurotoxicity [J].
Rizzo, Stefano ;
Riviere, Celine ;
Piazzi, Lorna ;
Bisi, Alessandra ;
Gobbi, Silvia ;
Bartolini, Manuela ;
Andrisano, Vincenza ;
Morroni, Fabiana ;
Tarozzi, Andrea ;
Monti, Jean-Pierre ;
Rampa, Angela .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (10) :2883-2886
[12]   ME3SICL-NAI-CH3CN AS AN EFFICIENT AND PRACTICAL REDUCING AGENT FOR BENZYLIC ALCOHOLS [J].
SAKAI, T ;
MIYATA, K ;
UTAKA, M ;
TAKEDA, A .
TETRAHEDRON LETTERS, 1987, 28 (33) :3817-3818
[13]   Treatment of Alzheimer's disease: current status and new perspectives [J].
Scarpini, E ;
Scheltens, P ;
Feldman, H .
LANCET NEUROLOGY, 2003, 2 (09) :539-547
[14]  
Singh M., 2016, RSC ADV, V6
[15]   Design, synthesis, biological evaluation and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors [J].
Wang, Chaolei ;
Wu, Zheng ;
Cai, Hao ;
Xu, Shengtao ;
Liu, Jie ;
Jiang, Jieyun ;
Yao, Hequan ;
Wu, Xiaoming ;
Xu, Jinyi .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) :5212-5216
[16]   Design, synthesis, biological evaluation, and docking study of 4-isochromanone hybrids bearing N-benzyl pyridinium moiety as dual binding site acetylcholinesterase inhibitors (part II) [J].
Wang, Jia ;
Wang, Chaolei ;
Wu, Zheng ;
Li, Xinnan ;
Xu, Shengtao ;
Liu, Jie ;
Lan, Qinying ;
Zhu, Zheying ;
Xu, Jinyi .
CHEMICAL BIOLOGY & DRUG DESIGN, 2018, 91 (03) :756-762
[17]   Discovery of a Potential Anti-Ischemic Stroke Agent: 3-Pentylbenzo[c]thiophen-1(3H)-one [J].
Wu, Jing ;
Ling, Jingjing ;
Wang, Xuliang ;
Li, Tingting ;
Liu, Jingchao ;
Lai, Yisheng ;
Ji, Hui ;
Peng, Sixun ;
Tian, Jide ;
Zhang, Yihua .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7173-7181
[18]   Design, synthesis and evaluation of novel tacrine coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease [J].
Xie, Sai-Sai ;
Wang, Xiao-Bing ;
Li, Jiang-Yan ;
Yang, Lei ;
Kong, Ling-Yi .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2013, 64 :540-553
[19]   Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease [J].
Zhang, Chao ;
Du, Qiao-Yi ;
Chen, Lang-Di ;
Wu, Wen-Hao ;
Liao, Si-Yan ;
Yu, Li-Hong ;
Liang, Xin-Tong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 116 :200-209
[20]   Multi-target design strategies for the improved treatment of Alzheimer's disease [J].
Zhang, Pengfei ;
Xu, Shengtao ;
Zhu, Zheying ;
Xu, Jinyi .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 176 :228-247